AAAAAA
Results:
1-11
|
Results: 11
Authors:
Simon, AD
Warshofsky, MK
Schwartz, A
Citation: Ad. Simon et al., Restenosis: The clinical problem, PERSP A SCI, 3, 1999, pp. 1-19
Authors:
Januzzi, JL
Edelman, ER
Citation: Jl. Januzzi et Er. Edelman, The pathobiology of restenosis - A paradigm from clinical and experimentalstudies, PERSP A SCI, 3, 1999, pp. 21-34
Authors:
Zalewski, A
Shi, Y
Ormont, ML
Citation: A. Zalewski et al., Coronary repair and restenosis cellular basis for antisense approaches, PERSP A SCI, 3, 1999, pp. 35-44
Authors:
Leopold, JA
Loscalzo, J
Citation: Ja. Leopold et J. Loscalzo, Vascular smooth muscle cell biology and restenosis, PERSP A SCI, 3, 1999, pp. 45-69
Authors:
Husain, M
Simons, M
Citation: M. Husain et M. Simons, Vascular antisense therapy directed against c-myc, c-myb and PCNA, PERSP A SCI, 3, 1999, pp. 71-98
Authors:
Lebedeva, IV
Stein, CA
Citation: Iv. Lebedeva et Ca. Stein, Phosphorothioate oligodeoxynucleotides as inhibitors of gene expression: Antisense and non-antisense effects, PERSP A SCI, 3, 1999, pp. 99-118
Authors:
Gibbons, GH
Citation: Gh. Gibbons, Molecular therapies for vascular disease: Altering the balance between cell growth and cell death, PERSP A SCI, 3, 1999, pp. 119-132
Authors:
Wyatt, JR
Stein, CA
Citation: Jr. Wyatt et Ca. Stein, Oligonucleotides containing the G-quartet sequence motif, PERSP A SCI, 3, 1999, pp. 133-140
Authors:
Rabbani, LE
Simon, AD
Wang, WZ
Citation: Le. Rabbani et al., Non-G-quartet, non-sequence specific antirestenotic effects of phosphorothioate oligodeoxynucleotides, PERSP A SCI, 3, 1999, pp. 141-151
Authors:
Drachman, DE
Edelman, ER
Rogers, C
Citation: De. Drachman et al., Local delivery of antirestenotic drugs, PERSP A SCI, 3, 1999, pp. 153-161
Authors:
Bennett, MR
Schwartz, SM
Citation: Mr. Bennett et Sm. Schwartz, Critical considerations and future directions, PERSP A SCI, 3, 1999, pp. 163-179
Risultati:
1-11
|